This product is a non-hypergalactosylated human monoclonal antibody with glycoslyated site in Fc region. The glycoengineered antibody D2E7 has reduced anti-drug immune respone, it specifically binds TNFα and can be potentially used in the treatment of Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and ulcerative colitis.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-768 | Anti-TNF alpha Recombinant Antibody (Nerelimomab) | FuncS, IF, Neut, ELISA, FC, IP, ICC | IgG1 |
TAB-112CQ | Anti-Human TNF Recombinant Antibody (A10G10) | Neut, ELISA, WB | |
TAB-116CQ | Anti-Human TNF Recombinant Antibody (Vh5/Vk12) | ELISA | |
TAB-117CQ | Anti-Human TNF Recombinant Antibody (TSK114) | ELISA, WB | |
TAB-123CQ | Mouse Anti-TNF Recombinant Antibody (TAB-123CQ) | ELISA, Neut | Mouse IgG |
There are currently no Customer reviews or questions for Gly-083LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.